NL6607516A - - Google Patents

Info

Publication number
NL6607516A
NL6607516A NL6607516A NL6607516A NL6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A
Authority
NL
Netherlands
Application number
NL6607516A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL6607516A priority Critical patent/NL6607516A/xx
Priority to FR82837A priority patent/FR5953M/fr
Priority to GB22620/67A priority patent/GB1131007A/en
Priority to IL28009A priority patent/IL28009A/en
Priority to SE06961/67A priority patent/SE354417B/xx
Priority to GR670133861A priority patent/GR33861B/el
Priority to ES340956A priority patent/ES340956A1/es
Priority to SU1158241A priority patent/SU510986A3/ru
Priority to DE1617576A priority patent/DE1617576C3/de
Priority to US641483A priority patent/US3557280A/en
Priority to BE699091D priority patent/BE699091A/xx
Priority to NO00168375A priority patent/NO126298B/no
Priority to AT502267A priority patent/AT272522B/de
Priority to DK282167AA priority patent/DK117587B/da
Priority to IT37118/67A priority patent/IT1140250B/it
Priority to YU1086/67A priority patent/YU31326B/xx
Priority to FI1517/67A priority patent/FI43622B/fi
Priority to FR108345A priority patent/FR1529966A/fr
Priority to CS3970A priority patent/CS151454B2/cs
Priority to CH766867A priority patent/CH490087A/de
Priority to JP42034292A priority patent/JPS5010373B1/ja
Priority to LU53788A priority patent/LU53788A1/xx
Publication of NL6607516A publication Critical patent/NL6607516A/xx
Priority to MY15/71A priority patent/MY7100015A/xx
Priority to US05/267,087 priority patent/US3957972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6607516A 1966-05-31 1966-05-31 NL6607516A (en:Method)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (en:Method) 1966-05-31 1966-05-31
FR82837A FR5953M (en:Method) 1966-05-31 1966-11-08
GB22620/67A GB1131007A (en) 1966-05-31 1967-05-16 Improvements in or relating to aqueous solutions of oxytetracycline
IL28009A IL28009A (en) 1966-05-31 1967-05-18 Process for the preparation of stable solutions of oxytetracycline in water,suitable for parenteral and peroral administration
SE06961/67A SE354417B (en:Method) 1966-05-31 1967-05-18
GR670133861A GR33861B (el) 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.
ES340956A ES340956A1 (es) 1966-05-31 1967-05-24 Procedimiento para la preparacion de soluciones estables deoxitetraciclina en agua adecuadas para administracion paren-teral, peronal y local.
SU1158241A SU510986A3 (ru) 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина
DE1617576A DE1617576C3 (de) 1966-05-31 1967-05-26 Verfahren zur Herstellung eines Injektionspräparates auf Basis einer wäßrigen Lösung eines Oxytetracyclin-Magnesium-Komplexes
US641483A US3557280A (en) 1966-05-31 1967-05-26 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
BE699091D BE699091A (en:Method) 1966-05-31 1967-05-26
NO00168375A NO126298B (en:Method) 1966-05-31 1967-05-30
AT502267A AT272522B (de) 1966-05-31 1967-05-30 Verfahren zur Herstellung von stabilen, für die parenterale und perorale Verabreichung geeigneten wässerigen Lösungen von Oxytetracyclin
DK282167AA DK117587B (da) 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
IT37118/67A IT1140250B (it) 1966-05-31 1967-05-30 Procedimento per la preparazione di soluzioni stabili di ossitetraciclina in acqua, adatte per somministrazioni per via parenterale ed orale
YU1086/67A YU31326B (en) 1966-05-31 1967-05-30 Postupak za dobijanje stabilnog vodenog rastvora oksitetraciklina pogodnog za parenteralnu, peroralnu i lokalnu upotrebu
FI1517/67A FI43622B (en:Method) 1966-05-31 1967-05-30
FR108345A FR1529966A (fr) 1966-05-31 1967-05-30 Procédé de préparation de solutions aqueuses stables d'oxytétracycline
CS3970A CS151454B2 (en:Method) 1966-05-31 1967-05-31
CH766867A CH490087A (de) 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen
JP42034292A JPS5010373B1 (en:Method) 1966-05-31 1967-05-31
LU53788A LU53788A1 (en:Method) 1966-05-31 1967-05-31
MY15/71A MY7100015A (en) 1966-05-31 1971-12-30 Improvements in or relating to aqueous solutions of oxytetracycline
US05/267,087 US3957972A (en) 1966-05-31 1972-06-28 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (en:Method) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
NL6607516A true NL6607516A (en:Method) 1967-12-01

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6607516A NL6607516A (en:Method) 1966-05-31 1966-05-31

Country Status (22)

Country Link
US (1) US3557280A (en:Method)
JP (1) JPS5010373B1 (en:Method)
AT (1) AT272522B (en:Method)
BE (1) BE699091A (en:Method)
CH (1) CH490087A (en:Method)
CS (1) CS151454B2 (en:Method)
DE (1) DE1617576C3 (en:Method)
DK (1) DK117587B (en:Method)
ES (1) ES340956A1 (en:Method)
FI (1) FI43622B (en:Method)
FR (1) FR5953M (en:Method)
GB (1) GB1131007A (en:Method)
GR (1) GR33861B (en:Method)
IL (1) IL28009A (en:Method)
IT (1) IT1140250B (en:Method)
LU (1) LU53788A1 (en:Method)
MY (1) MY7100015A (en:Method)
NL (1) NL6607516A (en:Method)
NO (1) NO126298B (en:Method)
SE (1) SE354417B (en:Method)
SU (1) SU510986A3 (en:Method)
YU (1) YU31326B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (en:Method) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
EP1666453A1 (en) * 1999-09-14 2006-06-07 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
WO2001052858A1 (en) 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
AU2001251157A1 (en) * 2000-03-31 2001-10-15 Paratek Pharmaceuticals, Inc 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
CA2409063A1 (en) 2000-05-15 2001-11-22 Mark L. Nelson 7-substituted fused ring tetracycline compounds
US20020128238A1 (en) * 2000-06-16 2002-09-12 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
US20040224927A1 (en) 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
EP1301465A2 (en) 2000-07-07 2003-04-16 Trustees Of Tufts College 13-substituted methacycline compounds
CA2415718C (en) * 2000-07-07 2012-08-28 Trustees Of Tufts College 7-substituted tetracycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
WO2002004404A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 7,8 and 9-substituted tetracycline compounds
HU229577B1 (en) 2000-07-07 2014-02-28 Tufts College 9-substituted minocycline derivatives
HUP0402047A3 (en) 2001-03-13 2012-10-29 Paratek Pharmaceuticals 7,9-substituted tetracycline compounds, their use and pharmaceutical compositions containing them
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
WO2002072031A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as synergistic antifungal agents
WO2002072022A2 (en) 2001-03-14 2002-09-19 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
ES2338994T3 (es) 2001-04-24 2010-05-14 Paratek Pharmaceuticals, Inc. Compuestos de tetraciclina sustituida para el tratamiento de la malaria.
WO2003057169A2 (en) 2002-01-08 2003-07-17 Paratek Pharmaceuticals, Inc. 4-dedimethylamino tetracycline compounds
EA200802365A1 (ru) 2002-03-08 2009-08-28 Паратек Фармасьютикалс, Инк. Аминометилзамещенные тетрациклиновые соединения
CN101712632A (zh) 2002-03-21 2010-05-26 帕拉特克药品公司 取代的四环素化合物
CA2492273C (en) 2002-07-12 2013-02-05 Paratek Pharmaceuticals, Inc. 3, 10, and 12a substituted tetracycline compounds
EP2277504A1 (en) 2002-10-24 2011-01-26 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
WO2004071490A1 (en) * 2003-02-12 2004-08-26 R & P Korea Co., Ltd. Solvent system of hardly soluble drug with improved elution rate
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
AU2004259659B2 (en) 2003-07-09 2011-11-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US20050137174A1 (en) 2003-07-09 2005-06-23 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CA2553510C (en) * 2004-01-15 2012-09-25 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP2269978A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
WO2006047671A2 (en) * 2004-10-25 2006-05-04 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP1848685A1 (en) 2005-02-04 2007-10-31 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
CA2616224A1 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
CA2622704A1 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
AU2007208214B2 (en) 2006-01-24 2013-02-14 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
EP2857386B1 (en) * 2006-04-24 2017-02-22 Teva Pharmaceutical Industries Ltd Tigecycline crystalline forms and processes for preparation thereof
JP2009543544A (ja) * 2006-05-15 2009-12-10 パラテック ファーマシューティカルズ インコーポレイテッド 置換されたテトラサイクリン化合物を用いて、遺伝子または遺伝子産物の発現を調節する方法
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
PL2120963T3 (pl) 2006-12-21 2019-05-31 Paratek Pharm Innc Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry
EP3812372A3 (en) 2006-12-21 2021-06-30 Paratek Pharmaceuticals, Inc. 7-heterocyclyl substituted sancycline derivatives for treating bacterial, viral and parasitic infections (e.g. malaria) or inflammatory diseases
AU2008239606A1 (en) * 2007-04-12 2008-10-23 Paratek Pharmaceuticals, Inc. Methods for treating spinal muscular atrophy using tetracycline compounds
US9434680B2 (en) 2007-04-27 2016-09-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
US9522872B2 (en) 2007-07-06 2016-12-20 Paratek Pharmaceuticals, Inc. Methods for synthesizing substituted tetracycline compounds
KR20100126469A (ko) 2008-03-05 2010-12-01 파라테크 파마슈티컬스, 인크. 미노사이클린 화합물 및 이들의 사용 방법
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US20100022483A1 (en) * 2008-04-14 2010-01-28 Paratek Pharmaceuticals, Inc. Substituted Tetracycline Compounds
TW202021946A (zh) 2008-05-19 2020-06-16 美商派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
BRPI0916344A2 (pt) 2008-07-21 2020-07-21 Albemarle Corporation grânulos com alto teor de ibuprofeno de sódio, preparação e utilização para preparação de formas de dosagem sólidas não efervescentes
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
AP2011005631A0 (en) * 2008-09-19 2011-04-30 Paratek Pharmaceuticals Ind Tetracycline compounds for the treatment of rheumatoid arthritis and related methods of treatment.
AU2010233089B2 (en) 2009-04-10 2016-05-26 Tufts Medical Center, Inc. Par-1 activation by metalloproteinase-1 (MMP-1)
PL2707003T3 (pl) 2011-05-12 2019-11-29 Paratek Pharm Innc Krystaliczne sole amidu kwasu (4s,4as,5ar,12as)-4-dimetyloamino-3,10,12,12a-tetrahydroksy-7-[(metoksy(metylo)amino)metylo]-1,11-diokso- 1,4,4a,5,5a,6,11,12a-oktahydronaftaceno- 2-karboksylowego i sposoby ich stosowania
AU2017353588B2 (en) 2016-11-01 2022-07-14 Paratek Pharmaceuticals, Inc. 9-aminomethyl minocycline compounds and use thereof in treating Community-Acquired Bacterial Pneumonia (CABP)
US20200222432A1 (en) 2017-07-21 2020-07-16 Almirall, Llc. Treatment of non-inflammatory lesions

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Also Published As

Publication number Publication date
YU31326B (en) 1973-04-30
SE354417B (en:Method) 1973-03-12
NO126298B (en:Method) 1973-01-22
GB1131007A (en) 1968-10-16
FR5953M (en:Method) 1968-04-16
IL28009A (en) 1970-08-19
GR33861B (el) 1968-02-09
DE1617576C3 (de) 1980-12-11
DK117587B (da) 1970-05-11
DE1617576A1 (de) 1972-04-27
US3557280A (en) 1971-01-19
ES340956A1 (es) 1968-06-16
MY7100015A (en) 1971-12-31
IT1140250B (it) 1986-09-24
JPS5010373B1 (en:Method) 1975-04-21
CS151454B2 (en:Method) 1973-10-19
SU510986A3 (ru) 1976-04-15
CH490087A (de) 1970-05-15
LU53788A1 (en:Method) 1967-07-31
FI43622B (en:Method) 1971-02-01
DE1617576B2 (de) 1980-04-10
BE699091A (en:Method) 1967-11-27
AT272522B (de) 1969-07-10

Similar Documents

Publication Publication Date Title
JPS5010373B1 (en:Method)
AU5917865A (en:Method)
AU428063B2 (en:Method)
AU424443B2 (en:Method)
AU414526B2 (en:Method)
AU433222B2 (en:Method)
AU421822B2 (en:Method)
AU417216B2 (en:Method)
AU415165B1 (en:Method)
AU6703465A (en:Method)
AU612166A (en:Method)
AU5895065A (en:Method)
AU1144366A (en:Method)
AU218666A (en:Method)
BE447356A (en:Method)
BE597652A (en:Method)
AU433620A (en:Method)
AU407778B2 (en:Method)
BE691033A (en:Method)
AU415780B2 (en:Method)
AU411645B2 (en:Method)
AU6852465A (en:Method)
AU855865A (en:Method)
AU92366A (en:Method)
BE284991A (en:Method)